Respira Labs, a health tech company specializing in respiratory care, has announced the launch of Sylvee, an AI-powered chest wearable designed to assess users' lung function.
According to the company, the product was initially created to assess COPD, COVID-19, and asthma patients but has since been further developed for general lung health monitoring. The device works by using embedded microphones and speakers that measure acoustic resonance as a proxy for changes in lung air volume. In other words, Sylvee sends noise into the lung and then measures the kind of sounds that that noise produces.
Sylvee is meant to be worn by patients on their lower rib cage and can be used all day long to monitor their lung function continuously. "Our goal is to flag abnormalities early, enable earlier treatment at home and empower patients to manage their health," said a spokesperson from Respira Labs.
Lung Health Wearables
Respira Introduces New AI Wearable Designed to Assess Patients Lung Function
Trend Themes
1. AI-powered Health Wearables - The development of AI-powered wearable technology provides an opportunity for health tech companies to create devices for specific patient groups or general health monitoring.
2. Continuous Lung Function Monitoring - The trend towards continuous monitoring of lung function provides opportunities for the development of wearable devices that measure and transmit data without the need for invasive procedures.
3. Acoustic Diagnostic Devices - The use of acoustic resonance to measure changes in lung air volume presents opportunities for health tech companies to develop diagnostic devices that use non-invasive methods to assess lung health.
Industry Implications
1. Health Tech - The health tech industry can incorporate the trend of AI-powered wearable technology to develop devices that continuously monitor patients' health.
2. Medical Devices - The medical device industry can explore the trend of non-invasive acoustic diagnostic devices to create devices that assess lung health without requiring invasive procedures.
3. Respiratory Care - The respiratory care industry can leverage the trend of continuous lung function monitoring to create devices that monitor and transmit data for patients with respiratory conditions like COPD, COVID-19, and asthma.